Psychiatry and Clinical Psychopharmacology
Case Report

Brexpiprazole for a Patient with Ekbom Syndrome with Intolerable Side Effect of Aripiprazole

1.

Department of Psychiatry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan

2.

Tzu Chi University, School of Medicine, Hualien, Taiwan

Psychiatry and Clinical Psychopharmacology 2024; 34: 272-274
DOI: 10.5152/pcp.2024.24865
Read: 46 Downloads: 34 Published: 25 September 2024

Abstract
Ekbom’s syndrome (ES), also referred to as delusional parasitosis, is a psychiatric disorder that is relatively uncommon. It is characterized by a robust and unwavering belief in infestation despite the absence of predominant hallucinations or formal thought disorders. Ekbom syndrome presents in 2 main forms: primary, marked by delusions and abnormal tactile sensations; and secondary, where symptoms arise due to another underlying organic condition. In primary ES, the therapeutic approach primarily relies on antipsychotic (AP) medications. This article presents a case with primary ES showing that atypical APs with aripiprazole and brexpiprazole effectively treat this disease. Brexpiprazole, compared to aripiprazole, induced less tremor and akathisia in the case report, suggesting it might be more suitable for treating this condition.

Cite this article as: Shen Y-C, Hsiao C-Y. Brexpiprazole for a patient with Ekbom syndrome with intolerable side effect of aripiprazole. Psychiatry Clin Psychopharmacol. 2024;34(3):272-274.

Files
EISSN 2475-0581